Suppr超能文献

通过绿色纳米技术和纳米阿育吠陀医学治疗乳腺癌的新方法——临床前和初步人体临床研究。

New Approaches in Breast Cancer Therapy Through Green Nanotechnology and Nano-Ayurvedic Medicine - Pre-Clinical and Pilot Human Clinical Investigations.

机构信息

Department of Radiology, University of Missouri, Columbia, MO 65212, USA.

Institute of Green Nanotechnology, University of Missouri, Columbia, MO 65212, USA.

出版信息

Int J Nanomedicine. 2020 Jan 13;15:181-197. doi: 10.2147/IJN.S219042. eCollection 2020.

Abstract

PURPOSE

The overarching objective of this investigation was to investigate the intervention of green nanotechnology to transform the ancient holistic Ayurvedic medicine scientifically credible through reproducible formulations and rigorous pre-clinical/clinical evaluations.

METHODS

We provide, herein, full details: (i) on the discovery and full characterization of gold nanoparticles-based Nano Swarna Bhasma (henceforth referred to as NSB drug); (ii) In vitro anti-tumor properties of NSB drug in breast tumor cells; (iii) pre-clinical therapeutic efficacy studies of NSB drug in breast tumor bearing SCID mice through oral delivery protocols and (iv) first results of clinical translation, from mice to human breast cancer patients, through pilot human clinical trials, conducted according to the Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (abbreviated as AYUSH) regulatory guidelines of the Government of India in metastatic breast cancer patients.

RESULTS

The preclinical in vitro and in vivo investigations, in breast tumor bearing mice, established unequivocally that the NSB Nano-Ayurvedic medicine-gold nanoparticles-based drug is highly effective in controlling the growth of breast tumors in a dose dependent fashion in vivo. These encouraging pre-clinical results prompted us to seek permission from the Indian Government's holistic medicine approval authority, AYUSH, for conducting clinical trials in human patients. Patients treated with the NSB drug capsules along with the "standard of care treatment" (Arm B) exhibited 100% clinical benefits when compared to patients in the treatment Arm A, thus indicating the tremendous clinical benefits of NSB drug in adjuvant therapy.

CONCLUSION

We have succeeded in clinically translating, from mice to humans, in using proprietary combinations of gold nanoparticles and phytochemicals to develop the Nano-Ayurvedic drug: Nano Swarna Bhasma (NSB), through innovative green nanotechnology, for treating human metastatic breast cancer patients.

摘要

目的

本研究的总体目标是通过可重复的配方和严格的临床前/临床评估,将绿色纳米技术干预转化为古老的整体阿育吠陀医学,使其具有科学可信度。

方法

我们在此提供了完整的细节:(i)金纳米粒子基纳米斯瓦纳巴斯马(简称 NSB 药物)的发现和全面表征;(ii)NSB 药物在乳腺癌细胞中的体外抗肿瘤特性;(iii)通过口服给药方案在荷瘤 SCID 小鼠中进行 NSB 药物的临床前治疗效果研究;(iv)根据印度政府的阿育吠陀、瑜伽和自然疗法、尤纳尼、悉达和顺势疗法(简称 AYUSH)监管指南,从老鼠到人类乳腺癌患者的临床转化的初步结果,进行了临床试验。

结果

在荷瘤小鼠的临床前体内外研究中,明确证实了 NSB 纳米阿育吠陀药物在体内以剂量依赖的方式控制乳腺癌肿瘤生长的高度有效性。这些令人鼓舞的临床前结果促使我们向印度政府的整体医学批准机构 AYUSH 寻求许可,以便在人类患者中进行临床试验。与接受 NSB 药物胶囊加“标准治疗”(B 组)的患者相比,接受治疗的患者表现出 100%的临床益处,这表明 NSB 药物在辅助治疗中具有巨大的临床益处。

结论

我们成功地通过创新的绿色纳米技术,将金纳米粒子和植物化学物质的专有组合从老鼠临床转化为人类,开发出纳米阿育吠陀药物:纳米斯瓦纳巴斯马(NSB),用于治疗人类转移性乳腺癌患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d52/6970107/b2e3adf4824f/IJN-15-181-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验